Eaton Vance Management’s AtriCure ATRC Stock Holding History

Eaton Vance Management’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,096	Closed	-$203K	–	1584
2022 Q1	$203K	Buy	3,096 +1	+0%	+$65	﹤0.01%	1747
2021 Q4	$215K	Hold	3,095	–	–	﹤0.01%	1542
2021 Q3	$215K	Sell	3,095 -29	-0.9%	-$2.23K	﹤0.01%	1324
2021 Q2	$248K	Sell	3,124 -277	-8%	-$20.1K	﹤0.01%	1533
2021 Q1	$223K	Buy	+3,401	New	+$209K	﹤0.01%	1438

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Eaton Vance Management's ATRC Position: Q2 2022 in Review

Eaton Vance Management sold out of AtriCure (ATRC) in Q2 2022, closing a stake of 3,096 shares — an estimated $203K sold.

Eaton Vance Management first reported a position in ATRC in Q1 2021 and held it in 5 quarters. The position peaked at $248K in Q2 2021. 213 funds tracked by Wall St. Rank hold ATRC as of Q2 2022.

Eaton Vance Management reported no remaining AtriCure position as of Q2 2022 after selling out during the quarter.
Eaton Vance Management sold 3,096 AtriCure shares in Q2 2022, an estimated $203K.
Eaton Vance Management first reported a position in AtriCure in Q1 2021 and held it in 5 quarters.
Eaton Vance Management's AtriCure position peaked at $248K in Q2 2021.
213 funds tracked by Wall St. Rank held AtriCure as of Q2 2022.

Based on Eaton Vance Management's 13F filing for Q2 2022, filed 15 Aug 2022.